INIS
juveniles
100%
patients
54%
antigens
45%
antibodies
36%
arthritis
36%
control
27%
viruses
27%
children
18%
data
9%
surfaces
9%
diseases
9%
comparative evaluations
9%
host
9%
values
9%
hepatitis
9%
sex
9%
pneumonia
9%
mycoplasma
9%
Immunology and Microbiology
Dermatomyositis
72%
Titer
45%
Juvenile Idiopathic Arthritis
36%
Antigen
27%
Monospecific Antibody
18%
Enterovirus B
18%
Myositis
18%
Sample
18%
Immune Response
9%
Prevalence
9%
Neutralizing Antibody
9%
HBsAg
9%
Polymyositis
9%
Mycoplasma pneumoniae
9%
Virus Antibody
9%
Virus Antigen
9%
Age
9%
Virus
9%
Pharmacology, Toxicology and Pharmaceutical Science
Juvenile Dermatomyositis
63%
Juvenile Rheumatoid Arthritis
36%
Antigen
27%
Antibody
18%
Myositis
18%
Enterovirus B
18%
Diseases
9%
Prevalence
9%
Antivirus Agent
9%
Pathophysiology
9%
Virus Antibody
9%
Neutralizing Antibody
9%
Virus Antigen
9%
Polymyositis
9%
Mycoplasma Pneumonia
9%
Dermatomyositis
9%
Host
9%
Virus
9%
Syndrome
9%
Hepatitis B Surface Antigen
9%